Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Da Xing

Showing results (501-510 of 503) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 503 results.
Orthopaedic Surgery|November 22, 2019
Novel Surgical Strategy for Treating Osteoporotic Vertebral Fractures with Cord CompressionDan-Qing Guo, Miao Yu, Shun-Cong Zhang, et al.
Frontiers in Genetics|January 23, 2024
Polyketide synthases mutation in tuberculosis transmission revealed by whole genomic sequence, China, 2011-2019Ting-Ting Wang, Yuan-Long Hu, Yi-Fan Li, et al.
CA: a Cancer Journal for Clinicians|March 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 studyJian-Chun Duan, Jia Zhong, Bo-Yang Sun, et al.
Pageof 51

Showing results (501-510 of 503) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 503 results.
Orthopaedic Surgery|November 22, 2019
Novel Surgical Strategy for Treating Osteoporotic Vertebral Fractures with Cord CompressionDan-Qing Guo, Miao Yu, Shun-Cong Zhang, et al.
Frontiers in Genetics|January 23, 2024
Polyketide synthases mutation in tuberculosis transmission revealed by whole genomic sequence, China, 2011-2019Ting-Ting Wang, Yuan-Long Hu, Yi-Fan Li, et al.
CA: a Cancer Journal for Clinicians|March 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 studyJian-Chun Duan, Jia Zhong, Bo-Yang Sun, et al.
Pageof 51